INTIBIA Pivotal Study
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Catherine Matthews, MD
Wake Forest University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bergman Clinics, Women'S Health, Department of Gynecology
Amsterdam, Netherlands
- Isala Zwolle
Zwolle, Netherlands
- Cedars-Sinai Medical Group
Beverly Hills, California, United States
- Urology Group of Southern California
Los Angeles, California, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Advanced Urology Associates
Daytona Beach, Florida, United States
- Southeastern Urogynecology & Pelvic Surgery
Moultrie, Georgia, United States
- Rosemark Womencare Specialists
Idaho Falls, Idaho, United States
- Cypress Medical Research Center, Llc
Wichita, Kansas, United States
- Baystate Medical Center
Springfield, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Advanced Urogynecology of Michigan
Dearborn, Michigan, United States
- Specialty Clinical Research of St. Louis
St Louis, Missouri, United States
- Atlantic Health System - Amg Urology (garden State Urology)
Denville, New Jersey, United States
- Wake Forest University
Winston-Salem, North Carolina, United States
- the Urology Group
Cincinnati, Ohio, United States
- Metrohealth System
Cleveland, Ohio, United States
- the Institute for Female Pelvic Medicine and Reconstructive Surgery- Axia Womens Health
Allentown, Pennsylvania, United States
- Midlantic Urology
Bala-Cynwyd, Pennsylvania, United States
- the Female Pelvic Health Center
Newtown, Pennsylvania, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- Houston Metro Urology
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Mar 2022
- Primary completion
- 12 May 2025
- Completion
- 27 Jun 2026
- Last update posted
- 2 Mar 2026
- Registered enrollment
- 208
- Registry id
- NCT05250908
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.